• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老与肾脏疾病:应对新挑战的旧问题

Aging and Renal Disease: Old Questions for New Challenges.

作者信息

Chou Yu-Hsiang, Chen Yung-Ming

机构信息

1Department of Internal Medicine, National Taiwan University Hospital Jin-Shan Branch, New Taipei City 20844, Taiwan.

2Renal Division, Department of Internal Medicine, and.

出版信息

Aging Dis. 2021 Apr 1;12(2):515-528. doi: 10.14336/AD.2020.0703. eCollection 2021 Apr.

DOI:10.14336/AD.2020.0703
PMID:33815880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7990354/
Abstract

Chronic kidney disease (CKD) is a growing problem among aging population, and the number of individuals at risk of end stage renal disease is rising. Part of the reason lies in incomplete understanding of the pathways underlying renal aging and kidney disease, as well as insufficient delivery of evidence-based treatment to elderly patients with CKD. This review aims to address these unsolved issues by delineating updated mechanisms of renal senescence and summarizing recent findings on key clinical aspects of CKD in the elderly. Challenges and obstacles in caring for older people with CKD are discussed, with an emphasis on modification of risk factors, prevention of acute kidney injury, stabilization of progression and decision on dialysis initiation.

摘要

慢性肾脏病(CKD)在老龄化人群中是一个日益严重的问题,处于终末期肾病风险的个体数量正在增加。部分原因在于对肾脏衰老和肾病潜在机制的理解不完整,以及对老年CKD患者基于证据的治疗提供不足。本综述旨在通过阐述肾脏衰老的最新机制和总结老年人CKD关键临床方面的最新研究结果来解决这些未解决的问题。讨论了照顾老年CKD患者的挑战和障碍,重点是危险因素的修正、急性肾损伤的预防、疾病进展的稳定以及透析起始的决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c59c/7990354/99494be75e37/ad-12-2-515-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c59c/7990354/99494be75e37/ad-12-2-515-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c59c/7990354/99494be75e37/ad-12-2-515-g1.jpg

相似文献

1
Aging and Renal Disease: Old Questions for New Challenges.衰老与肾脏疾病:应对新挑战的旧问题
Aging Dis. 2021 Apr 1;12(2):515-528. doi: 10.14336/AD.2020.0703. eCollection 2021 Apr.
2
End-Stage Kidney Disease in the Elderly: Approach to Dialysis Initiation, Choosing Modality, and Predicting Outcomes.老年终末期肾病:透析起始的方法、透析方式的选择及预后预测
Adv Chronic Kidney Dis. 2016 Jan;23(1):36-43. doi: 10.1053/j.ackd.2015.08.005.
3
Rethinking Chronic Kidney Disease in the Aging Population.重新审视老年人群中的慢性肾脏病
Life (Basel). 2022 Oct 28;12(11):1724. doi: 10.3390/life12111724.
4
Chronic kidney disease in the elderly.老年人慢性肾脏病。
Clin Geriatr Med. 2013 Aug;29(3):611-24. doi: 10.1016/j.cger.2013.05.003.
5
Kidney Disease in Diabetes糖尿病肾病
6
Aging and chronic kidney disease.衰老与慢性肾脏病。
Kidney Blood Press Res. 2013;38(1):109-20. doi: 10.1159/000355760. Epub 2014 Mar 3.
7
OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES.老年慢性肾脏病患者:定义以及生物标志物和药物对心血管及肾脏结局的影响
J Ren Care. 2016 Sep;42(3):150-61. doi: 10.1111/jorc.12164. Epub 2016 Jun 30.
8
Chronic kidney disease (CKD) in the elderly -- a geriatrician's perspective.老年慢性肾脏病——老年医学专家的观点
Aging Male. 2007 Sep;10(3):113-37. doi: 10.1080/13685530701419096.
9
Kidney disease and aging: A reciprocal relation.肾脏疾病与衰老:一种相互关系。
Exp Gerontol. 2017 Jan;87(Pt B):156-159. doi: 10.1016/j.exger.2016.02.003. Epub 2016 Feb 12.
10
Contribution of genetics and epigenetics to progression of kidney fibrosis.遗传学和表观遗传学对肾纤维化进展的作用。
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv72-9. doi: 10.1093/ndt/gft025. Epub 2013 Aug 23.

引用本文的文献

1
Role of Fibroblast-Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures.成纤维细胞-免疫串扰在肾脏、肺和皮肤三级淋巴结构中的作用
Immunol Rev. 2025 Sep;334(1):e70059. doi: 10.1111/imr.70059.
2
Segatella copri and gut microbial ammonia metabolism contribute to chronic kidney disease pathogenesis.粪普雷沃氏菌和肠道微生物氨代谢促成慢性肾病的发病机制。
Nat Microbiol. 2025 Jun 24. doi: 10.1038/s41564-025-02039-y.
3
Association between methyl donor nutrients' dietary intake with phenotypic aging among US adults: a cross-sectional study from NHANES 2005-2018.

本文引用的文献

1
PPAR and Its Agonists in Chronic Kidney Disease.过氧化物酶体增殖物激活受体及其激动剂在慢性肾脏病中的作用
Int J Nephrol. 2020 Feb 25;2020:2917474. doi: 10.1155/2020/2917474. eCollection 2020.
2
Age-Dependent Definition of CKD.慢性肾脏病的年龄依赖性定义。
J Am Soc Nephrol. 2020 Feb;31(2):447. doi: 10.1681/ASN.2019090914. Epub 2019 Dec 23.
3
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.在真实临床实践中使用 SGLT2 抑制剂与肾脏结局的关联(CVD-REAL 3):一项多国家观察性队列研究。
美国成年人甲基供体营养素膳食摄入量与表型衰老之间的关联:一项基于2005 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究。
Sci Rep. 2025 Apr 12;15(1):12591. doi: 10.1038/s41598-025-96668-2.
4
Association between magnesium depletion score and Klotho levels among U.S. adults: Findings from NHANES 2007-2016.美国成年人中镁缺乏评分与Klotho水平之间的关联:2007 - 2016年美国国家健康与营养检查调查结果
Heliyon. 2025 Feb 19;11(4):e42809. doi: 10.1016/j.heliyon.2025.e42809. eCollection 2025 Feb 28.
5
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target.慢性肾脏病与衰老:剖析p53/p21信号通路作为治疗靶点
Biogerontology. 2024 Dec 26;26(1):32. doi: 10.1007/s10522-024-10173-z.
6
Rate of decline in kidney function with age: a systematic review.肾功能随年龄下降的速率:一项系统综述。
BMJ Open. 2024 Nov 27;14(11):e089783. doi: 10.1136/bmjopen-2024-089783.
7
Analysis of risk factors for changes of renal artery resistance indexes in gout patients by ultrasound colour Doppler.痛风患者肾动脉阻力指数变化的超声彩色多普勒危险因素分析
Rheumatol Adv Pract. 2024 Aug 9;8(4):rkae094. doi: 10.1093/rap/rkae094. eCollection 2024.
8
Characterization of age-associated inflammasome activation reveals tissue specific differences in transcriptional and post-translational inflammatory responses.与年龄相关的炎性小体激活的特征揭示了转录和翻译后炎症反应中的组织特异性差异。
Immun Ageing. 2024 Sep 10;21(1):60. doi: 10.1186/s12979-024-00462-z.
9
Chronic kidney disease and the alternative labels used by GPs in Australia: a qualitative interview study.慢性肾病与澳大利亚全科医生使用的替代标签:一项定性访谈研究
BJGP Open. 2025 Apr 24;9(1). doi: 10.3399/BJGPO.2024.0031. Print 2025 Apr.
10
Association of retinal age gap with chronic kidney disease and subsequent cardiovascular disease sequelae: a cross-sectional and longitudinal study from the UK Biobank.视网膜年龄差距与慢性肾脏病及后续心血管疾病后遗症的关联:来自英国生物银行的一项横断面和纵向研究
Clin Kidney J. 2024 Jul 4;17(7):sfae088. doi: 10.1093/ckj/sfae088. eCollection 2024 Jul.
Lancet Diabetes Endocrinol. 2020 Jan;8(1):27-35. doi: 10.1016/S2213-8587(19)30384-5.
4
The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people.更新后的台湾版PIM标准:老年人潜在不适当用药清单。
Ther Adv Chronic Dis. 2019 Oct 5;10:2040622319879602. doi: 10.1177/2040622319879602. eCollection 2019.
5
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
6
CKD: A Call for an Age-Adapted Definition.CKD:呼吁制定适合年龄的定义。
J Am Soc Nephrol. 2019 Oct;30(10):1785-1805. doi: 10.1681/ASN.2019030238. Epub 2019 Sep 10.
7
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
8
Efficacy of pentoxifylline treatment for neonatal sepsis: a meta-analysis of randomized controlled studies.己酮可可碱治疗新生儿败血症的疗效:随机对照研究的荟萃分析。
Ital J Pediatr. 2019 Aug 22;45(1):108. doi: 10.1186/s13052-019-0697-8.
9
CREDENCE and DELIGHT deliver on renal benefits.CREDENCE和DELIGHT带来肾脏益处。
Nat Rev Nephrol. 2019 Aug;15(8):459-460. doi: 10.1038/s41581-019-0171-2.
10
Rejuvenation: Turning back the clock of aging kidney. rejuvenation: turning back the clock of aging kidney.
J Formos Med Assoc. 2020 May;119(5):898-906. doi: 10.1016/j.jfma.2019.05.020. Epub 2019 Jun 13.